Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial
Chang Tang,1,2,* Lanting Wang,1,2,* Zihua Chen,1,2,* Jin Yang,1,2 Haiqing Gao,1,2 Chenggong Guan,1,2 Qiaozhi Gu,1,2 Shan He,1,2 Fanping Yang,1,2 Shengan Chen,1,2 Li Ma,1,2 Zhen Zhang,1,2 Ying Zhao,1,2 Lin Tang,1,2 Yu Xu,1,2 Yue Hu,3 Xiaoqun Luo1,2 1Department of Allergy &...
Saved in:
Main Authors: | Tang C (Author), Wang L (Author), Chen Z (Author), Yang J (Author), Gao H (Author), Guan C (Author), Gu Q (Author), He S (Author), Yang F (Author), Chen S (Author), Ma L (Author), Zhang Z (Author), Zhao Y (Author), Tang L (Author), Xu Y (Author), Hu Y (Author), Luo X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling
by: Zhang L, et al.
Published: (2015) -
Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?
by: Huang Y, et al.
Published: (2019) -
Rapid Response in an Uncertain Environment: Study of COVID-19 Scientific Research Under the Parallel Model
by: Cheng X, et al.
Published: (2022) -
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
by: Huo R, et al.
Published: (2022) -
Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
by: Wang K, et al.
Published: (2022)